[1]“江西省人民政府 图文实录 《江西省加速消除宫颈癌行动暨适龄女生HPV疫苗接种民生实事》新闻发布会在南昌举行.http://www.jiangxi.gov.cn/art/2023/8/8/art_5862_4563199.html?xxgkhide=1
[2]中国疫苗行业协会免疫规划规范化管理与实践分会. 青少年女性人乳头瘤病毒疫苗免疫策略与实践长三角地区专家共识 [J] . 中华预防医学杂志, 2023, 57(2) : 135-153. DOI: 10.3760/cma.j.cn112150-20221110-01093.
[3]子宫颈癌等人乳头瘤病毒相关疾病免疫预防专家共识[J]. 中华预防医学杂志, 2019,53(8):43.
[4]HPV Information Centre. Human Papillomavirus and Related Diseases Report,WORLD(Version posted at www.hpvcentre.net on 10 March 2023)
[5]HPV Information Centre. Human Papillomavirus and Related Diseases Report,CHINA(Version posted at www.hpvcentre.net on 10 March 2023)
[6]Bruni L, Albero G, Serrano B, et al. Human Papillomavirus and Related Diseases in World [R]. Barcelona: ICO/IARC Information Centre on HPV and Cancer, 2021.
[7]胡尚英, 郑荣寿, 赵方辉, 等 . 1989至 2008年中国女性子宫颈癌发病和死亡趋势分析[J]. 中国医学科学院学报, 2014,
36(2):119 125. DOI: 10.3881/j.issn.1000 503X.2014.02.001.
[8] 孟令昊, 胥秋艳, 李科, 等 . 1990~2019 年中国女性宫颈癌疾病负担变化的分析[J]. 中国循证医学杂志, 2021, 21(6): 648 653. DOI: 10.7507/1672 2531.202101091.
[9] Chen W Q , Zhang S W , Zou X N ,et al.Cancer incidence and mortality in China, 2013[J].Chinese Journal of Cancer Research, 2011, 23(001):3-9.DOI:10.1007/s11670-011-0003-9.
[10]中华医学会妇科肿瘤学分会, 中国优生科学协会阴道镜和宫颈病理学分会. 人乳头瘤病毒疫苗临床应用中国专家共识[J]. 中国妇产科临床杂志, 2021.
[11]Martel C D , Plummer M , Vignat J ,et al.Worldwide burden of cancer attributable to HPV by site, country and HPV type[J].International Journal of Cancer, 2017, 141(4).DOI:10.1002/ijc.30716.
[12]Lei J, Ploner A, Elfström KM, et al. HPV Vaccination and the Risk of Invasive Cervical Cancer[J]. N Engl J Med, 2020, 383(14):1340 1348. DOI: 10.1056/NEJMoa1917338.
[13] World Health Organization. HPV Vaccine Global Market Study [EB/OL].https://www./publications/m/item/who hpv vaccine global market study april 2022.
[14]WHO.Vaccine in National Immunization Programme Update[EB/OL] .(2020-06-04)
[15]Bruni L, Saura Lázaro A, Montoliu A, et al. HPV vaccination introduction worldwide and WHO and UNICEF estimates of national HPV immunization coverage 2010 2019[J]. Prev Med, 2021, 144: 106399. DOI: 10.1016/j.ypmed.2020.106399.
[16]夏昌发, 乔友林, 张勇, 等. WHO全球消除宫颈癌战略及我国面临的挑战和应对策略[J]. 中华医学杂志, 2020, 100(44): 3484-3488. DOI: 10.3760/cma.j.cn112137 20200909 02606.
[17]https://www.gov.cn/zhengce/zhengceku/2023-01/21/content_5738364.htm
[18]HU Y M, GUO M, LI C G, et al. Immunogenicity noninferiority study of 2 doses and 3 doses of an Escherichia coli-produced HPV bivalent vaccine in girls vs. 3 doses in young women[J]. Sci China Life Sci, 2020, 63(4):582-591.
[19]杨旭. 人乳头瘤病毒主要衣壳蛋白的优化表达[D].北京协和医学院,2015.